相关实验视频
Updated: Jul 28, 2025

06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
208
在患有性结肠炎的日本患者中,疾病活性和勃起功能障碍
Shinya Furukawa1, Eiji Takeshita2, Teruki Miyake3
1Health Services Center, Ehime University, Matsuyama, Ehime 790-8577, Japan.
Sexual medicine
|May 31, 2023
概括
在日本患有性结肠炎 (UC) 的患者中,疾病活性与勃起功能障碍 (ED) 无关. 然而,在这个人群中,衰老被发现是ED的独立风险因素.
科学领域:
- 胃肠病学 胃肠病学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 男人的健康 男人的健康
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎 (UC),是勃起功能障碍 (ED) 的已知危险因素.
- 结核病活动与ED患病率之间的关系尚不清楚.
- 以前的研究表明,IBD活动与ED之间存在不一致的关联.
研究的目的:
- 在日本男性患者中调查UC疾病活动和ED之间的关联.
- 确定导致UC患者ED的因素.
主要方法:
- 招募了165名日本男性UC患者.
- 收集的数据包括男性性健康库存 (SHIM) 评分,药物和UC严重程度.
- ED被定义为SHIM得分<17;严重的ED被定义为SHIM得分<8.
主要成果:
- 在UC严重程度和ED之间没有发现任何关联.
- 勃起障碍的患病率为64.9%,严重勃起障碍的患病率为47.9%.
- 年龄较大 (≥63岁) 与ED (aOR,12.93) 和严重ED (aOR,9.02) 独立相关.
结论:
- 脑膜炎疾病的严重程度似乎与ED的患病率无关.
- 衰老是UC患者ED的重要独立风险因素.
- 需要进一步的研究,考虑到使用SHIM分数进行ED评估的局限性.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
181
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
181
Inflammatory Bowel Disease I: Ulcerative Colitis
227
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
227
Inflammatory Bowel Disease IV: Pharmacological Management
159
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
159
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
161
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
161
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
205
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
205
Inflammatory Bowel Disease II: Crohn's Disease
306
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
306

